| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $53.3M | -29.1% | -46.1% |
| Cost of Revenue | $44.0M | -1.7% | +8.9% |
| Gross Profit | $9.2M | -69.6% | -84.2% |
| R&D Expense | $58.8M | +0.8% | -0.9% |
| SG&A Expense | $23.6M | -8.4% | -6.8% |
| Operating Income | -$140.4M | -25.2% | -60.3% |
| Pre-tax Income | -$133.2M | -27.5% | -66.8% |
| Income Tax | $174K | -26.6% | -48.2% |
| Net Income | -$133.4M | -27.4% | -66.3% |
| EPS (Basic) | -$0.94 | -25.3% | -51.6% |
| EPS (Diluted) | -$0.94 | -25.3% | -51.6% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $88.8M | -13.9% | -29.0% |
| Short-term Investments | $533.1M | -6.8% | -11.0% |
| Accounts Receivable | $123.6M | -9.2% | -31.5% |
| Current Assets | $782.7M | -7.5% | -15.9% |
| Total Assets | $895.8M | -6.8% | -15.1% |
| Current Liabilities | $118.9M |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$135.8M | — | — |
| Capital Expenditures | $1.6M | — | — |
| Investing Cash Flow | $51.2M | — | — |
| Financing Cash Flow | $9.1M | — | — |
| Free Cash Flow | -$137.4M | — | — |
| -13.8% |
| Total Liabilities | $176.3M | -6.9% | -9.6% |
| Stockholders' Equity | $719.5M | -6.8% | -16.4% |